Familial Transmission of emm12 Group A Streptococcus

Emerg Infect Dis. 2017 Oct;23(10):1745-1746. doi: 10.3201/eid2310.170343.

Abstract

Incidence and severity of invasive group A Streptococcus infections are of increasing concern in France and worldwide. The risk for secondary infection of close contacts is known but rarely described. We report a case of intrafamilial and life-threatening transmission of emm12 group A Streptococcus.

Keywords: C-reactive; NSAIDs; Streptococcus pyogenes; amoxicillin-clavulanic acid; antibacterial; antibiotic; antimicrobial drug; bacteria; emm12; familial; group A Streptococcus; group A streptococcal infections; iGAS; invasive; leukocyte; linezolid; nonsteroidal anti-inflammatory drugs; polymorphonuclear; procalcitonin.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amoxicillin-Potassium Clavulanate Combination / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Bursitis / drug therapy
  • Bursitis / microbiology*
  • Bursitis / pathology
  • Contraindications, Drug
  • Disease Transmission, Infectious
  • Fasciitis, Necrotizing / drug therapy
  • Fasciitis, Necrotizing / microbiology*
  • Fasciitis, Necrotizing / pathology
  • Female
  • Humans
  • Male
  • Spouses
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / microbiology
  • Streptococcal Infections / pathology
  • Streptococcal Infections / transmission*
  • Streptococcus pyogenes / drug effects
  • Streptococcus pyogenes / growth & development
  • Streptococcus pyogenes / pathogenicity*

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Amoxicillin-Potassium Clavulanate Combination